FDA pauses enforcement of in-person dispensing requirement for abortion pill

by on

The FDA will not enforce a decades-old policy requiring mifepristone be dispensed in person, citing the risk of COVID-19 exposure for to patients and providers.

The FDA will not enforce a decades-old policy requiring mifepristone be dispensed in person, citing the risk of COVID-19 exposure for to patients and providers.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: